Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma

Journal of Thoracic Oncology

Volumn 5, Issue 9, 2010, Pages 1467-1471

  Kelty, Clive J ^a   Kennedy, Catherine W ^b   Falk, Gregory L ^a,b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Esophageal cancer; Esophagectomy; Lymphadenectomy; Staging

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 77956282459     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181e8f6b1     Document Type: Article

References (26)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
2. Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004;91:943-947.
3. Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 2005;6: 864-870.
4. Stein HJ, von Rahden BHA, Siewert JR. Survival after oesophagectomy for oesophageal cancer. Langenbecks Arch Surg 2005;4:280-285.
5. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566-573.
6. Tachibana M, Kinugasa S, Hirahara N, et al. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Car-diothorac Surg 2008;34:427-431.
7. Sobin LH, Wittekind C (Eds.). TNM Classification of Malignant Tumours (UICC S.), 6th Ed. Hoboken, NJ: John Wiley & Sons Inc. 2002.
8. Greene FL, Page DL, Fleming ID (Eds.). AJCC Cancer Staging Manual, 6th Ed. New York, NY: Springer, 2002.
9. Roder JD, Busch R, Stein HJ, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-413.
10. Ellis FH Jr, Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1997;113: 836-846.
11. Korst RJ, Rusch VW, Venkatraman E, et al. Proposed revision for the staging classification of esophageal cancer. J Thorac Cardiovasc Surg 1998;115:660-670.
12. Nigro JJ, DeMeester SR, Hagen JA, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999;117:960-968.
13. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520-530.
14. Rice TW, Blackstone EH, Rybicki LA, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 2003;125:1103-1113.
15. Bollschweiler E, Baldus SE, Schröder W, et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol 2006; 94:355-363.
16. Rizk N, Venkatraman E, Park B, et al; American Joint Committee on Cancer staging system. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006;132:1374-1381.
17. Barbour AP, Rizk NP, Gonen M, et al. Lymphadenectomy for adeno-carcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 2007;14:306-316.
18. Bogoevski D, Noken F, Koenig A, et al. Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 2008;247:633-641.
19. Mariette C, Piessen G, Briez N, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neo-adjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008; 247:365-367.
20. Greenstein AJ, Litle VR, Swanson SJ, et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 2008;206:239-246.
21. Edge SB, Byrd DR, Compton CC, et al. (Eds.). AJCC Cancer Staging Manual, 7th Ed. New York, NY: Springer, 2010.
22. Martin DJ, Church NG, Kennedy CW, et al. Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients. Dis Esophagus 2008;21: 612-618.
23. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Cox D. Regression models and life tables (with discussion). J R Stat Soc 1972;187-220.
25. Pramesh CS, Kulkarni NN, Mistry RC, et al. Lymphadenectomy in cancer: time for a paradigm shift? Lancet Oncol 2006;7:450-451.
26. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226-234.